Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


EMA Releases New Guidelines for Direct-acting Antivirals in Patients with Hepatitis C
The European Medicines Agency (EMA) released guidelines recommending screening for hepatitis B in patients who are infected with hepatitis C prior to starting treatment with direct-acting antivirals.
Purdue University Research Group Links HBV Infection with Poor Liver Cancer Prognosis
Researchers from Purdue University have discovered a connection between hepatitis B (HBV) infection and liver cancer.
Why Are HCV-Infected Immigrants More Likely to End Up Hospitalized for Liver Problems?
Why do more HCV-infected immigrants, rather than non-immigrants, end up hospitalized for liver problems? Inadequate screening and longer infection duration are likely reasons.
Delayed Antimicrobial Hypersensitivity: Immunology and Diagnostics
In a review article, researchers share current understanding of the pathogenesis of type IV T cell-dependent immune-mediated ADRs and review the evidence for diagnostics for T cell-mediated ADRs.
Buyers Clubs Big Business for HIV and HCV Drugs
Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.
Hepatitis C: Is a Vaccine in the Near Future?
Researchers have not been able to develop a vaccine for hepatitis C, which causes 700,000 deaths around the world annually, and now, a new study shows why developing a vaccine for the virus has been so difficult.
Veterans Co-Infected with HCV and HIV Use Healthcare System at a Higher Rate
A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.
FDA Adds Black Box Warning to Direct-acting Antivirals: Relevance and Guidelines for Managing the New Warning
The FDA has released a warning on the risk of reactivation of hepatitis B virus in some patients receiving direct-action antivirals to treat hepatitis C infection.
Big advances in treatment can